VA
Vivek Ashok Kumar Patel
About Vivek Ashok Kumar Patel
Data last updated:
Vivek Ashok Kumar Patel is a Managing Director at Accretion Pharmaceuticals Limited (since 2023), Director at Accretion Nutraveda Limited (since 2021) and Director at Accretion Nutraveda Limited (since 2021). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹89.49 Cr; the largest is Accretion Pharmaceuticals Limited at ₹57.47 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Accretion Pharmaceuticals Limited L21004GJ2023PLC146545 | Managing Director | 29 Nov 2023 | 2023 | ₹57.47 Cr (FY 2025) | Active |
 Accretion Nutraveda Limited U24290GJ2021PLC121216 | Director | 31 Mar 2021 | 2021 | ₹16.01 Cr (FY 2025) | Active |
| Accretion Nutraveda Limited L24290GJ2021PLC121216 | Director | 31 Mar 2021 | 2021 | ₹16.01 Cr (FY 2025) | Active |
Board colleagues of Vivek Ashok Kumar Patel
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Ashok Kumar Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Ashok Kumar Patel
Vivek Ashok Kumar Patel currently holds 3 directorships: Accretion Pharmaceuticals Limited (Managing Director, since 29 Nov 2023, revenue ₹57.47 Cr (FY 2025)); Accretion Nutraveda Limited (Director, since 31 Mar 2021, revenue ₹16.01 Cr (FY 2025)); Accretion Nutraveda Limited (Director, since 31 Mar 2021, revenue ₹16.01 Cr (FY 2025)).
Vivek Ashok Kumar Patel was first appointed on 31 Mar 2021 as Director at Accretion Nutraveda Limited. The most recent appointment on record is 29 Nov 2023 at Accretion Pharmaceuticals Limited.
The 3 current companies of Vivek Ashok Kumar Patel that report revenue have a combined latest revenue of ₹89.49 Cr: Accretion Pharmaceuticals Limited ₹57.47 Cr (FY 2025); Accretion Nutraveda Limited ₹16.01 Cr (FY 2025); Accretion Nutraveda Limited ₹16.01 Cr (FY 2025).
The current boards of Vivek Ashok Kumar Patel's companies include Chand Rameshbhai Kanabar (Accretion Pharmaceuticals Limited), Grishma A Shewale (Accretion Pharmaceuticals Limited), Hardik Mukundbhai Prajapati (Accretion Pharmaceuticals Limited), Harshad Nanubhai Rathod (Accretion Pharmaceuticals Limited), Harshad Nanubhai Rathod (Accretion Pharmaceuticals Limited), Mayur Popatlal Sojitra (Accretion Pharmaceuticals Limited), among others.